Diversified Healthcare Trust (DHC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
5 Feb, 2026Executive summary
Normalized FFO exceeded expectations, driven by revenue growth, expense management, and a 27% year-over-year increase in SHOP same property NOI, alongside double-digit rent growth in the medical office and life sciences segment.
Portfolio includes 370 properties valued at $7.2 billion across 36 states and D.C., with 8.4 million sq. ft. of life science and medical office space and over 27,000 senior living units.
Total revenues for Q2 2024 were $371.4 million, up 7.3% from Q2 2023, driven by higher resident fees and services in the SHOP segment.
NOI increased 12.2% year-over-year to $67.3 million in Q2 2024, with SHOP segment NOI up 26.6% and Medical Office and Life Science Portfolio NOI up 2.9%.
Managed by The RMR Group, which oversees $41 billion in assets as of June 30, 2024.
Financial highlights
Q2 2024 revenues: $371.4 million (Q2 2023: $346.2 million); net loss of $97.9 million ($0.41 per share), up from $72.6 million loss in Q2 2023.
Normalized FFO for Q2 2024 was $6.8 million ($0.03/share), down 43.7% year-over-year but up 93.9% sequentially.
Adjusted EBITDAre rose 10.9% year-over-year to $68.9 million; consolidated same property cash basis NOI was $68.8 million, up 8.7% year-over-year.
SHOP segment NOI grew 27% year-over-year and 17% sequentially; occupancy up 160 bps YoY and 20 bps sequentially.
Ended Q2 with $266 million in unrestricted cash and equivalents.
Outlook and guidance
Full-year SHOP NOI guidance reaffirmed at $120 million-$140 million; Q3 SHOP NOI expected at $31 million-$36 million.
CapEx guidance for 2024 reduced to $200 million-$220 million, with SHOP CapEx lowered to $130 million-$150 million.
Management expects continued positive trends in SHOP segment occupancy and rates, with cost increases in labor, insurance, and food expected to moderate.
Anticipates most SHOP NOI growth in the second half of 2024, supported by positive July move-in trends.
Company believes it will be able to refinance or obtain additional debt to satisfy $440 million of senior unsecured notes due June 2025.
Latest events from Diversified Healthcare Trust
- Updated sustainability metrics and climate risk strategies underscore ongoing ESG leadership.DHC
Proxy filing25 Mar 2026 - Proxy covers trustee elections, say-on-pay, auditor ratification, and robust ESG and governance practices.DHC
Proxy filing19 Mar 2026 - Trustee elections, executive pay, and auditor ratification headline the June 2026 meeting.DHC
Proxy filing19 Mar 2026 - Record NOI growth, margin expansion, and debt reduction drive strong shareholder returns.DHC
Q4 202524 Feb 2026 - Record 2025 returns, SHOP growth, and capital recycling drive strong outlook for 2026.DHC
Investor presentation24 Feb 2026 - Q1 2025 delivered 4.3% revenue growth, narrowed net loss, and strong SHOP segment gains.DHC
Q1 20255 Feb 2026 - Q3 2025 revenue up, SHOP improved, but net loss rose on impairments and transitions.DHC
Q3 20255 Feb 2026 - Q4 revenue up 5%, SHOP NOI up 56%, and a $7.2B portfolio supports debt reduction.DHC
Q4 20245 Feb 2026 - SHOP segment drives NOI growth, but net loss widens amid asset sales and cost pressures.DHC
Q3 20245 Feb 2026